Literature DB >> 15467901

Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service.

Stefan Kuhle1, Patricia Massicotte, Anthony Chan, Margaret Adams, Mohamed Abdolell, Gabrielle de Veber, Lesley Mitchell.   

Abstract

Thromboembolism (TE) has recently been recognized as a clinical entity in children. Determining the clinical characteristics of pediatric TE is an important first step in dealing with this new disorder. The paper summarizes 1776 consecutive children with systemic TE referred to 1-800-NO-CLOTS telephone consultation service. 1-800-NO-CLOTS is a free consultation service for clinicians managing pediatric TE. Patient information was collected immediately using standardized forms. In children with systemic TE, infants under one year of age (47%) including neonates (26%) represented the largest distinct pediatric age group. Age-related differences were seen in TE locations, associated conditions, and risk factors. However, venous TE was the most frequent manifestation (74%). Neonates and children with cardiac disorders were more likely to have an arterial TE than a venous TE Beyond the neonatal period, venous TE associated with a central line is more likely to occur than arterial TE. Children with ALL were 5.7 times more likely to have a venous TE than an arterial TE. TE were infrequent in otherwise healthy children with 90% of children having at least one risk factor. Central catheters were the single most common risk factor associated with TE, present in 2/3 of children. Ultrasound was most frequently employed for diagnosis of TE. Finally, there was marked heterogeneity in treatment of children with TE. In children, neonates form the largest single group with TE. TE usually occur only in the presence of one or more risk factors with catheters being the single most important factor.

Entities:  

Mesh:

Year:  2004        PMID: 15467901     DOI: 10.1160/TH04-04-0207

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  Phlegmasia cerulea dolens in a teenage boy found to have Factor V Leiden.

Authors:  Emily Junck; Sachita Shah
Journal:  BMJ Case Rep       Date:  2015-04-02

2.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates.

Authors:  R Goldsmith; A K Chan; B A Paes; M D Bhatt
Journal:  J Perinatol       Date:  2015-07-16       Impact factor: 2.521

4.  Incidence and risk factors for venous thromboembolism in critically ill children with cardiac disease.

Authors:  Sheila J Hanson; Rowena C Punzalan; Melissa A Christensen; Nancy S Ghanayem; Evelyn M Kuhn; Peter L Havens
Journal:  Pediatr Cardiol       Date:  2011-09-07       Impact factor: 1.655

Review 5.  Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.

Authors:  Werner Streif; Walter Ageno
Journal:  Wien Med Wochenschr       Date:  2011-02

Review 6.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.

Authors:  Jacquelyn L Baskin; Ching-Hon Pui; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Scott C Howard
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

7.  Occurrence of Thromboembolism in Paediatric Patients With Inflammatory Bowel Disease: Data From the CEDATA-GPGE Registry.

Authors:  Jan De Laffolie; Antje Ballauff; Stefan Wirth; Carolin Blueml; Frank Risto Rommel; Martin Claßen; Martin Laaß; Thomas Lang; Almuthe Christina Hauer
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

8.  Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator.

Authors:  S D DeMeo; A Sherwood; C D Hornik; R N Goldberg; C M Cotten; M Bidegain
Journal:  J Perinatol       Date:  2014-07       Impact factor: 2.521

9.  Cerebral venous thrombosis treated with enoxaparin in an IUGR neonate with DIC.

Authors:  G Bertini; S Perugi; C Dani; D Prisco; C Fonda
Journal:  Childs Nerv Syst       Date:  2009-04-17       Impact factor: 1.475

Review 10.  [Prevention of perioperative venous thromboembolism in children].

Authors:  Werner Streif
Journal:  Wien Med Wochenschr       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.